DEUTSCHE BANK AG\ - PHARMATHENE INC ownership

PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 40 filers reported holding PHARMATHENE INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PHARMATHENE INC
ValueSharesWeighting
Q1 2017$67,000
-97.7%
84,022
-90.4%
0.00%
-100.0%
Q4 2016$2,855,000
+178.3%
879,067
+148.2%
0.00%
+100.0%
Q3 2016$1,026,000
+210.9%
354,160
+160.6%
0.00%
Q2 2016$330,000
+6500.0%
135,910
+4147.2%
0.00%
Q4 2014$5,000
+400.0%
3,200
+433.3%
0.00%
Q1 2014$1,000
-99.6%
600
-99.6%
0.00%
Q3 2013$280,000133,6000.00%
Other shareholders
PHARMATHENE INC shareholders Q4 2013
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 7,981,035$15,084,0003.59%
PERKINS CAPITAL MANAGEMENT INC 953,800$1,803,0002.26%
Nantahala Capital Management 3,251,838$6,390,0000.66%
Hudson Bay Capital Management LP 3,133,394$5,922,0000.28%
Visium Asset Management, LP 1,800,000$3,402,0000.06%
Burt Wealth Advisors 30,000$57,0000.05%
ONTARIO TEACHERS PENSION PLAN BOARD 1,520,451$2,874,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 594,444$1,124,0000.02%
Acrospire Investment Management LLC 6,000$11,0000.01%
TFS CAPITAL LLC 17,741$34,0000.01%
View complete list of PHARMATHENE INC shareholders